Literature DB >> 12040548

Patient characteristics and costs of severe sepsis and septic shock in Quebec.

Jacques Letarte1, Christopher J Longo, Johanne Pelletier, Bruno Nabonne, Harold N Fisher.   

Abstract

BACKGROUND: We investigated the cost of health care resources for the treatment of severe sepsis and/or septic shock patients.
MATERIALS AND METHODS: One hundred retrospective chart abstractions from patients with severe sepsis or septic shock were included. The average cost, per episode, through day 28, as well as an analysis of a patient subset through 1 year was calculated. Mean values for all abstracted patient's costs and outcomes, as well as analyses of the survivor and nonsurvivor populations, were undertaken. Data from the Canadian Institute for Health Information and recent published literature were used to estimate the number of severe sepsis cases, and the resulting burden of illness for Quebec.
RESULTS: The mean cost for all patients abstracted was $11,474 per episode of care ($1,064/day). The survivors had a mean cost for their treatment of $16,228 per episode of care ($877/day). The total cost per episode was $7,584 per nonsurvivor ($1,724/day). An average cost of $27,481 for survivors after day 28 through 1 year was calculated. The burden of severe sepsis was estimated to be $36.4 to $72.9 million per year, but higher if costs beyond day 28 are included.
CONCLUSIONS: The cost of severe sepsis is a significant burden to the Quebec health care system. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 12040548     DOI: 10.1053/jcrc.2002.33028

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  6 in total

Review 1.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

Review 2.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.

Authors:  Ana M C Sogayar; Flavia R Machado; Alvaro Rea-Neto; Amselmo Dornas; Cintia M C Grion; Suzana M A Lobo; Bernardo R Tura; Carla L O Silva; Ruy G R Cal; Idal Beer; Vilto Michels; Jorge Safi; Marcia Kayath; Eliezer Silva
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 4.  Bench to bedside: A role for erythropoietin in sepsis.

Authors:  Andrew P Walden; J Duncan Young; Edward Sharples
Journal:  Crit Care       Date:  2010-08-06       Impact factor: 9.097

5.  Increased 1-year healthcare use in survivors of severe sepsis.

Authors:  Hallie C Prescott; Kenneth M Langa; Vincent Liu; Gabriel J Escobar; Theodore J Iwashyna
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 30.528

6.  Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.

Authors:  Kathryn Coyle; Doug Coyle; Julie Blouin; Karen Lee; Mohammed F Jabr; Khai Tran; Lisa Mielniczuk; John Swiston; Mike Innes
Journal:  Pharmacoeconomics       Date:  2016-05       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.